The terminal deoxynucleotidyl transferase (TdT, or DNTT) is differentially expressed in brain metastatic tissues of patients with metastatic breast cancer.

Shahan Mamoor

DOI: https://doi.org/10.31219/osf.io/c7kt4

2020-11-22

Abstract:Metastasis to the brain is a serious complication of breast cancer (1-3) with limited treatment options (4, 5). We mined published microarray data (6, 7) to discover genes associated with brain metastasis in human breast cancer, and identified differential expression of the gene encoding the terminal deoxynucleotidyl transferase TdT, also known as DNTT, when comparing brain metastatic tissues to primary tumors of the breast. DNTT was expressed at significantly lower levels in metastasis to the brain as compared to primary tumors, and primary tumor expression of DNTT significantly correlated with relapse-free survival. We recently reported that the immunoglobulin light chain kappa constant locus, IGKC, was differentially expressed in the brain metastases of patients with metastatic breast cancer (8). These data indicate that the expression of an immunoglobulin gene segment as well as a critical part of the cellular machinery utilized in expression of rearranged immunoglobulin genes with complete diversity of the immunoglobulin repertoire is differentially expressed and down-regulated in brain metastatic breast cancer, suggesting limiting immunoglobulin repertoire diversity is important for metastasis to the brain.